Pioneering AI-Powered Breast Cancer Detection with ScreenPoint Medical and LifeVoxel

Kovey Kovalan

Revolutionizing Early Detection and Diagnosis with Transpara Software

ScreenPoint Medical, in partnership with LifeVoxel, is changing the game in early breast cancer detection and diagnosis. By making their groundbreaking Transpara mammography software accessible via standard internet connection, they give physicians access to life-saving AI technology that integrates seamlessly with existing legacy RIS/PACS systems. This collaboration has the potential to improve patient outcomes and lead the way in AI medical imaging.

About ScreenPoint Medical and Transpara

Founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady, ScreenPoint Medical aims to address breast cancer survival rates by utilizing Deep Learning (DL) and Artificial Intelligence (AI) to create Transpara, an advanced mammography solution. Transpara blends classic physics with AI to support diagnostic decision-making, going beyond current CAD systems to produce faster and more accurate results while reducing pressure on radiologists.

By assisting in the early detection of breast cancer and categorizing scans based on identified risk factors, Transpara provides a crucial second set of eyes for radiologists, reducing their workload by up to 70%.

"Using a 5mbps connection, Transpara rendered multi-gigabyte studies in seconds, illustrating the potential for full integration into legacy RIS/PACS systems."

Jon Paul Castorena - ScreenPoint Medical

Overcoming the AI Access Challenge

Despite Transpara's potential to revolutionize the healthcare industry, integrating the software into the existing workflows of physicians proved difficult. With the healthcare industry's resistance to cloud-based diagnostic solutions and the complexity of integrating with legacy systems, ScreenPoint Medical needed to address concerns and prove that Transpara could offer the speed, accuracy, convenience, and access necessary to support early breast cancer detection.

LifeVoxel's Powerful Patented Intelligent Cloud Solution

LifeVoxel's revolutionary cloud-based RIS/PACS platform provided a way forward for ScreenPoint Medical. Fully accessible on any device with diagnostic-grade images, end-to-end workflow management, and an online app market, LifeVoxel met all the requirements.

After initial discussions, ScreenPoint Medical and LifeVoxel collaborated to set up Transpara as a vendor on the LifeVoxel platform, integrate live updates of scan data, and perform testing. LifeVoxel met every request, resulting in a live demo product of Transpara available on the marketplace within just four weeks - significantly faster than the 12-month timeline typical of other PACS vendors.

Transforming Breast Cancer Imaging with Transpara and LifeVoxel

At the November 2022 Annual Radiological Society of North America (RSNA) meeting, ScreenPoint Medical showcased Transpara on the LifeVoxel platform. Delegates were impressed by the software's ability to render high-resolution images via the cloud. Furthermore, ScreenPoint Medical shared two studies demonstrating Transpara's potential to safely reduce workload in the clinical workflow of a double-reading breast cancer screening program while matching the clinical performance of breast cancer radiologists.

Thanks to LifeVoxel, ScreenPoint Medical's groundbreaking technology reached more radiologists and specialists, rendering multi-gigabyte studies in seconds even with a 5mbps connection, illustrating the potential for full integration into legacy RIS/PACS systems.

Key takeaways from the video

RSNA 2022 attendee was looking for a new PACS for the next decade

Believed all cloud based PACS solutions were dependent on high bandwidth
LifeVoxel demonstration used cloud to populate large 3GB Tomo 3D in seconds
Attendee was amazed there was a cloud solution independent of bandwidth speed

Jon Paul Castorena comments about the project

LifeVoxel enables AI integrated side-by-side while maintaining legacy systems
Previously, integrating AI into legacy systems took years
LifeVoxel technology easily integrates AI into physician workflows
LifeVoxel integrated ScreenPoint's Transpara in under 4 weeks

Harnessing the Full Power of AI and Cloud-Based Technology

The collaboration between ScreenPoint Medical and LifeVoxel leads the way in harnessing the full power of AI and cloud technology in the medical and healthcare industries. This partnership proves that AI technology can be integrated with legacy systems to reduce costs, shorten lead times, and minimize inconvenience for physicians. It also demonstrates that cloud-based technology doesn't have to be associated with poor upload/download speeds.

Transpara CAD markings displayed within LifeVoxel

LifeVoxel offers a 'real' cloud PACS solution, allowing Transpara to:

Display solely from a web browser
Undertake server-side rendering
Render images quickly (even on very slow Wi-Fi)
Provide full capability to triage, jump slice, and access CAD markings
With the initial barriers to adoption now overcome, ScreenPoint Medical can continue its mission to improve breast cancer survival rates through Transpara's industry-leading early detection capabilities.

The partnership between ScreenPoint Medical and LifeVoxel has successfully revolutionized early breast cancer detection and diagnosis. By combining AI technology with cloud-based solutions, they have created a powerful, accessible, and efficient system that integrates with existing infrastructure. As a result, radiologists and physicians can now access the life-saving benefits of Transpara software, improving patient outcomes and driving innovation in the medical imaging field.